Cargando…

Embolia cutis medicamentosa: an unusual adverse reaction to terlipressin

Terlipressin is a synthetic long-acting analog of vasopressin widely used to control variceal bleeding by lowering portal venous pressure. We report an unusual adverse reaction to terlipressin in a 78-year-old patient with esophageal variceal bleeding who developed skin necrosis soon after treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Gatos-Gatopoulos, Polychronis, Kostantoudakis, Stephanos, Panayiotides, Ioannis G., Dimitriadis, George D., Triantafyllou, Konstantinos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hellenic Society of Gastroenterology 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5670294/
https://www.ncbi.nlm.nih.gov/pubmed/29118569
http://dx.doi.org/10.20524/aog.2017.0158
_version_ 1783275997328572416
author Gatos-Gatopoulos, Polychronis
Kostantoudakis, Stephanos
Panayiotides, Ioannis G.
Dimitriadis, George D.
Triantafyllou, Konstantinos
author_facet Gatos-Gatopoulos, Polychronis
Kostantoudakis, Stephanos
Panayiotides, Ioannis G.
Dimitriadis, George D.
Triantafyllou, Konstantinos
author_sort Gatos-Gatopoulos, Polychronis
collection PubMed
description Terlipressin is a synthetic long-acting analog of vasopressin widely used to control variceal bleeding by lowering portal venous pressure. We report an unusual adverse reaction to terlipressin in a 78-year-old patient with esophageal variceal bleeding who developed skin necrosis soon after treatment initiation. Skin biopsy revealed embolia cutis medicamentosa.
format Online
Article
Text
id pubmed-5670294
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Hellenic Society of Gastroenterology
record_format MEDLINE/PubMed
spelling pubmed-56702942017-11-08 Embolia cutis medicamentosa: an unusual adverse reaction to terlipressin Gatos-Gatopoulos, Polychronis Kostantoudakis, Stephanos Panayiotides, Ioannis G. Dimitriadis, George D. Triantafyllou, Konstantinos Ann Gastroenterol Case Report Terlipressin is a synthetic long-acting analog of vasopressin widely used to control variceal bleeding by lowering portal venous pressure. We report an unusual adverse reaction to terlipressin in a 78-year-old patient with esophageal variceal bleeding who developed skin necrosis soon after treatment initiation. Skin biopsy revealed embolia cutis medicamentosa. Hellenic Society of Gastroenterology 2017 2017-05-11 /pmc/articles/PMC5670294/ /pubmed/29118569 http://dx.doi.org/10.20524/aog.2017.0158 Text en Copyright: © Hellenic Society of Gastroenterology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Gatos-Gatopoulos, Polychronis
Kostantoudakis, Stephanos
Panayiotides, Ioannis G.
Dimitriadis, George D.
Triantafyllou, Konstantinos
Embolia cutis medicamentosa: an unusual adverse reaction to terlipressin
title Embolia cutis medicamentosa: an unusual adverse reaction to terlipressin
title_full Embolia cutis medicamentosa: an unusual adverse reaction to terlipressin
title_fullStr Embolia cutis medicamentosa: an unusual adverse reaction to terlipressin
title_full_unstemmed Embolia cutis medicamentosa: an unusual adverse reaction to terlipressin
title_short Embolia cutis medicamentosa: an unusual adverse reaction to terlipressin
title_sort embolia cutis medicamentosa: an unusual adverse reaction to terlipressin
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5670294/
https://www.ncbi.nlm.nih.gov/pubmed/29118569
http://dx.doi.org/10.20524/aog.2017.0158
work_keys_str_mv AT gatosgatopoulospolychronis emboliacutismedicamentosaanunusualadversereactiontoterlipressin
AT kostantoudakisstephanos emboliacutismedicamentosaanunusualadversereactiontoterlipressin
AT panayiotidesioannisg emboliacutismedicamentosaanunusualadversereactiontoterlipressin
AT dimitriadisgeorged emboliacutismedicamentosaanunusualadversereactiontoterlipressin
AT triantafylloukonstantinos emboliacutismedicamentosaanunusualadversereactiontoterlipressin